Emmanuel COSSON
APHP, Hospital Avicenne · Assistance Publique - Hôpitaux de Paris · CHU-Jean Verdier
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Emmanuel COSSON as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:32 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05681533 · Epicardial Adipose Tissue and Arterial Stiffness in People Living With Diabetes (METAB-CV-PWV)Assistance Publique - Hôpitaux de Paris · unknown · Diabetic Patients · principal investigator
- N/ANCT05181631 · Diabetic/Metabolic Cardiomyopathy: Prevalence and PhenotypeAssistance Publique - Hôpitaux de Paris · unknown · Cardiopathy, Diabetes, Metabolic Syndrome · principal investigator
- N/ANCT03875755 · Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes MellitusAssistance Publique - Hôpitaux de Paris · active not recruiting · Gestational Diabetes Mellitus · principal investigator
- Ph3NCT03380546 · Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.Assistance Publique - Hôpitaux de Paris · terminated · Gestational Diabetes Mellitus in Pregnancy · principal investigator
- N/ANCT01022658 · INSUlin Regimens and VASCular FunctionsAssistance Publique - Hôpitaux de Paris · completed · Type 2 Diabetes · study chair
- N/ANCT00685984 · Peripheral Endothelial Function and Coronary Status in Asymptomatic Diabetic PatientsAssistance Publique - Hôpitaux de Paris · completed · Myocardial Ischemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:32 UTC. The ranking covers the 200 most relevant of 11 PubMed records, and a shared surname and initials can bring in a namesake. All 11 on PubMed
- Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients.Diabetes Metab · 200951 citationsRCR 1.5
- Prenatal education of overweight or obese pregnant women to prevent childhood overweight (the ETOIG study): an open-label, randomized controlled trial.Int J Obes (Lond) · 201928 citationsRCR 1.9
- Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients.Cardiovasc Diabetol · 201417 citationsRCR 0.6
- Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative.Diabetologia · 202213 citationsRCR 1.0
- Acute and long-term effects of saxagliptin on post-prandial glycemic response in obese patients with impaired glucose tolerance.Nutr Metab Cardiovasc Dis · 202110 citationsRCR 0.7
- Association Between Adherence To The French Dietary Guidelines And Lower Resting Heart Rate, Longer Diastole Duration, And Lower Myocardial Oxygen Consumption. The NUTRIVASC Study.Vasc Health Risk Manag · 20198 citationsRCR 0.4
- Noninvasive study of coronary microcirculation response to a cold pressor test.Eur J Clin Invest · 20157 citationsRCR 0.2
- Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients.Microvasc Res · 20184 citationsRCR 0.2
- Development of a statewide network hub for screening, referral, and enrollment into food as medicine programs across Kentucky.Front Public Health · 20254 citationsRCR 1.7
- Acute and long-term effects of saxagliptin on a set of cardiovascular targets measured at fasting and post-prandially in obese patients with impaired glucose tolerance: A placebo-controlled study.Nutr Metab Cardiovasc Dis · 20212 citationsRCR 0.1